Tissium announced today that it received FDA de novo marketing authorization for Coaptium Connect with Tissium Light.

Artificial heart developer Carmat says it faces financial insolvency by the end of the month.

Smith+Nephew this week announced it appointed Ajay Dhankhar as chief corporate development and strategy officer, effective ...

Medtronic this week announced it appointed Emory Healthcare CEO Dr. Joon Lee to its board as an independent director, ...

GE HealthCare (Nasdaq: GEHC) issued an urgent medical device correction related to its Carestation anesthesia monitoring ...

ForSight Robotics announced today that it completed a $125 million Series B funding round to support its ophthalmic robotic ...

Vivasure Medical announced today that it submitted its PerQSeal Elite vascular closure system to the FDA for premarket ...

Johnson & Johnson today announced it launched its Acuvue Oasys Max multifocal lens for patients with both astigmatism and ...

Ancora Heart announced it has reached the first enrollment milestone in its CORCINCH-HF pivotal trial evaluating the ...

Brain-computer interface (BCI) developer Science Corporation today said it submitted its Prima retinal implant for CE mark ...

Johnson & Johnson MedTech announced today that it launched new variable angle optimized locking technology (VOLT) plating ...

Levita Magnetics announced today that it received expanded FDA 510(k) clearance for its MARS (magnetic-assisted robotic ...